SCHEMBL4926780

SCHEMBL4926780

NC(=O)[C@@H]1CCCN1C(=O)c1cc2ccccc2cc1O

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.55
▸ SPHK2 Q9NRA0 1/20 0.49
▸ SPHK1 Q9NYA1 1/20 0.49
▸ HSP90AA1 P07900 3/20 0.46
▸ HSP90AB1 P08238 3/20 0.46
▸ PDK2 Q15119 1/20 0.46
▸ SCN9A Q15858 1/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAB9A P51151 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HTR1A P08908 1/20 0.43
▸ HTR7 P34969 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926777 1.00 RXFP1 (0.55) RXFP1SPHK2SPHK1HSP90AA1HSP90AB1
SCHEMBL4920860 0.85 RXFP1 (0.50) RXFP1HSP90AA1HSP90AB1NPC1MAPT
SCHEMBL4920854 0.85 RXFP1 (0.50) RXFP1HSP90AA1HSP90AB1NPC1MAPT
SCHEMBL4920412 0.80 LDHA (0.46) SPHK2SPHK1PDK2SCN9ANPC1
SCHEMBL4920407 0.80 LDHA (0.46) SPHK2SPHK1PDK2SCN9ANPC1
SCHEMBL4928498 0.77 DPP4 (0.51) SPHK2SPHK1PDK2SCN9ANPC1
SCHEMBL4928499 0.77 DPP4 (0.51) SPHK2SPHK1PDK2SCN9ANPC1
SCHEMBL11251214 0.76 SPHK2 (0.62) SPHK2SPHK1PDK2NPC1RAB9A
SCHEMBL11251209 0.76 SPHK2 (0.62) SPHK2SPHK1PDK2NPC1RAB9A
SCHEMBL13570470 0.75 SPHK1 (0.47) SPHK2SPHK1PDK2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 — — US claimed
JP-2008508348-A — — 2008-03-21 — — JP claimed
EP-1796681-A2 COMPOUNDS FOR INHIBITING COPPER-CONTAINING AMINE OXIDASES AND USES THEREOF Genmedica Therapeutics SL (ES) 2007-06-20 — — EP claimed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 — — US claimed
WO-2006013209-A2 COMPOUNDS FOR INHIBITING COPPER-CONTAINING AMINE OXIDASES AND USES THEREOF GENMEDICA THERAPEUTICS SL (ES) 2006-02-09 — — WO claimed
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 — — US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 RXFP1 3485/4885SPHK2 3951/4885SPHK1 3145/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 RXFP1 3683/4885SPHK2 3883/4885SPHK1 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback